T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptor-stimulated macrophages

Toll-like receptor (TLR) agonists represent potentially useful cancer vaccine adjuvants in their ability to stimulate antigen-presenting cells (APCs) and subsequently amplify the cytotoxic T-cell response. The purpose of this study was to characterize APC responses to TLR activation and to determine...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Immunotargets Ther
Päätekijät: Walk, Ryan M, Elliott, Steven T, Blanco, Felix C, Snyder, Jason A, Jacobi, Ashley M, Rose, Scott D, Behlke, Mark A, Salem, Aliasger K, Vukmanovic, Stanislav, Sandler, Anthony D
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2012
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4934151/
https://ncbi.nlm.nih.gov/pubmed/27471682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S32615
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia